After 90 days of follow up, they found only a slightly significant difference between the two regimens in terms of recurrent stroke, but no significant difference in bleeding events [ 10 ].
← all excerpts
Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review.
1
—
—